These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 19480552
1. Pharmacokinetics and first-pass effects of liquiritigenin in rats: low bioavailability is primarily due to extensive gastrointestinal first-pass effect. Kang HE, Cho YK, Jung HY, Choi KY, Sohn SI, Baek SR, Lee MG. Xenobiotica; 2009 Jun; 39(6):465-75. PubMed ID: 19480552 [Abstract] [Full Text] [Related]
2. Hepatic and intestinal first-pass effects of oltipraz in rats. Bae SK, Kim JW, Kim YH, Kim YG, Kim SG, Lee MG. Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718 [Abstract] [Full Text] [Related]
3. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects. Han KS, Lee MG. Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of isoliquiritigenin and its metabolites in rats: low bioavailability is primarily due to the hepatic and intestinal metabolism. Lee YK, Chin YW, Bae JK, Seo JS, Choi YH. Planta Med; 2013 Nov; 79(17):1656-65. PubMed ID: 24108436 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects. Shin HS, Bae SK, Lee MG. Int J Pharm; 2006 Aug 31; 320(1-2):64-70. PubMed ID: 16730145 [Abstract] [Full Text] [Related]
10. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Yang SH, Lee MG. Biopharm Drug Dispos; 2008 Oct 31; 29(7):414-26. PubMed ID: 18697186 [Abstract] [Full Text] [Related]
12. Dose-independent pharmacokinetics of metformin in rats: Hepatic and gastrointestinal first-pass effects. Choi YH, Kim SG, Lee MG. J Pharm Sci; 2006 Nov 31; 95(11):2543-52. PubMed ID: 16937336 [Abstract] [Full Text] [Related]
13. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats. Kim J, Han KS, Lee JW, Lee MG. Res Commun Mol Pathol Pharmacol; 1998 Nov 31; 102(2):125-36. PubMed ID: 10100504 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of liquiritigenin and its two glucuronides, M1 and M2, in rats with acute hepatitis induced by d-galactosamine/lipopolysaccharide or CCl(4). Kang HE, Kim YW, Sohn SI, Baek SR, Lee JW, Kim SG, Lee I, Lee MG. Xenobiotica; 2010 Jun 31; 40(6):424-36. PubMed ID: 20350053 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and first-pass metabolism of astaxanthin in rats. Choi HD, Kang HE, Yang SH, Lee MG, Shin WG. Br J Nutr; 2011 Jan 31; 105(2):220-7. PubMed ID: 20819240 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of amitriptyline and one of its metabolites, nortriptyline, in rats: little contribution of considerable hepatic first-pass effect to low bioavailability of amitriptyline due to great intestinal first-pass effect. Bae SK, Yang KH, Aryal DK, Kim YG, Lee MG. J Pharm Sci; 2009 Apr 31; 98(4):1587-601. PubMed ID: 18780336 [Abstract] [Full Text] [Related] Page: [Next] [New Search]